Sulfonylureas, Biguanides, and Repaglinide are all major classes of oral antidiabetic drugs used to treat type 2 diabetes. Sulfonylureas stimulate insulin secretion, Biguanides reduce hepatic gluconeogenesis, and Repaglinide is a meglitinide that stimulates insulin release.